BRPI0414331A - método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica - Google Patents
método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámicaInfo
- Publication number
- BRPI0414331A BRPI0414331A BRPI0414331-0A BRPI0414331A BRPI0414331A BR PI0414331 A BRPI0414331 A BR PI0414331A BR PI0414331 A BRPI0414331 A BR PI0414331A BR PI0414331 A BRPI0414331 A BR PI0414331A
- Authority
- BR
- Brazil
- Prior art keywords
- bacteria
- treatment area
- composition
- erythrosin
- patient treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
"MéTODO DE DESTRUIçãO DE BACTéRIA NUMA áREA DE TRATAMENTO DO PACIENTE E COMPOSIçãO ANTIMICROBIANA DE TERAPIA FOTODINáMICA". é revelado um método e uma composição para destruição de micróbios, especialmente bactéria, no corpo utilizando Eritrosina B junto com radiação eletromagnética. Num método preferido, uma composição compreendendo Eritrosina B é introduzida numa área de tratamento. Depois de um período suficiente de tempo decorrido, é aplicada radiação de um comprimento de onda apropriado à área para ativar a Eritrosina B e, por uma reação fotodinâmica, destruir a bactéria. A radiação preferida tem um comprimento de onda ao redor de 530 nm. A Eritrosina B é incorporada num gel, que atua de modo a restringir a ação fotodinâmica próxima ao biofilme, assegurando, deste modo, que apenas bactéria não desejada é afetada e a microfiora natural está incólume. Este método é efetivo para destruir pelo menos bactérias Gram-positivas e é particularmente efetivo em áreas em que os meios complexos tais como saliva também estão presentes.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50333903P | 2003-09-16 | 2003-09-16 | |
| US60/503,339 | 2003-09-16 | ||
| US10/860,297 | 2004-06-03 | ||
| US10/860,297 US20050059731A1 (en) | 2003-09-16 | 2004-06-03 | Erythrosin-based antimicrobial photodynamic therapy compound and its use |
| PCT/US2004/028726 WO2005032459A2 (en) | 2003-09-16 | 2004-09-03 | Erythrosin-based antimicrobial photodynamic therapy compound and its use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0414331A true BRPI0414331A (pt) | 2006-11-07 |
| BRPI0414331B1 BRPI0414331B1 (pt) | 2018-05-29 |
Family
ID=34278962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0414331-0A BRPI0414331B1 (pt) | 2003-09-16 | 2004-09-03 | "composição antimicrobiana de terapia fotodinâmica" |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050059731A1 (pt) |
| EP (1) | EP1778294A4 (pt) |
| JP (1) | JP4943149B2 (pt) |
| BR (1) | BRPI0414331B1 (pt) |
| MX (1) | MXPA06003033A (pt) |
| RU (1) | RU2368375C2 (pt) |
| WO (1) | WO2005032459A2 (pt) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7488757B2 (en) * | 2003-03-24 | 2009-02-10 | Becton, Dickinson And Company | Invisible antimicrobial glove and hand antiseptic |
| CN103767886B (zh) | 2005-11-09 | 2018-04-24 | 科洛斯科技公司 | 使牙齿增白的组合物及方法 |
| GB0525504D0 (en) | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
| US8512294B2 (en) * | 2006-07-28 | 2013-08-20 | Becton, Dickinson And Company | Vascular access device antimicrobial materials and solutions |
| US20100266989A1 (en) | 2006-11-09 | 2010-10-21 | Klox Technologies Inc. | Teeth whitening compositions and methods |
| WO2009052638A1 (en) * | 2007-10-25 | 2009-04-30 | Innovotech Inc. | Natural photodynamic agents and their use |
| SG191641A1 (en) * | 2008-04-04 | 2013-07-31 | Univ Singapore | A photosensitising composition and its uses |
| KR20180023070A (ko) | 2008-11-07 | 2018-03-06 | 클록스 테크놀로지스 인크. | 히알루론산, 글루코사민 또는 알란토인을 포함하는 산화성의 광활성화된 피부 회춘용 조성물 |
| GB0823265D0 (en) * | 2008-12-20 | 2009-01-28 | Convatec Technologies Inc | Antimicrobial Composition |
| US8821455B2 (en) * | 2009-07-09 | 2014-09-02 | Becton, Dickinson And Company | Antimicrobial coating for dermally invasive devices |
| SG177635A1 (en) | 2009-07-17 | 2012-03-29 | Klox Technologies Inc | Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease |
| US20110065798A1 (en) * | 2009-09-17 | 2011-03-17 | Becton, Dickinson And Company | Anti-infective lubricant for medical devices and methods for preparing the same |
| JP2013514867A (ja) | 2009-12-21 | 2013-05-02 | コルゲート・パーモリブ・カンパニー | 感光性色素を含むキット |
| EP2516002B1 (en) * | 2009-12-21 | 2014-04-23 | Colgate-Palmolive Company | Composition for treating and/or preventing conditions caused by microorganisms using an oral light device |
| DE102011075808B4 (de) * | 2010-09-10 | 2017-06-29 | Biolitec Ag | Implantat zur Anwendung bei einer photo-dynamischen Behandlung sowie Verfahren zur Herstellung des Implantats |
| GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
| EP2727603B1 (en) | 2011-07-01 | 2023-09-06 | SBI Pharmaceuticals Co., Ltd. | Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acid |
| US11116841B2 (en) * | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
| US20130281913A1 (en) * | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
| BR112015005593B1 (pt) | 2012-09-14 | 2019-09-24 | Valeant Pharmaceuticals International, Inc. | Método para branqueamento de dentes |
| KR20180110240A (ko) * | 2012-09-14 | 2018-10-08 | 클록스 테크놀로지스 인크. | 생체 광자성 용도를 위한 발색단 조합 |
| BR112015014816A2 (pt) | 2012-12-20 | 2017-07-11 | Convatec Technologies Inc | processamento de fibras celulósicas modificadas quimicamente |
| US9750928B2 (en) | 2013-02-13 | 2017-09-05 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
| US9695323B2 (en) | 2013-02-13 | 2017-07-04 | Becton, Dickinson And Company | UV curable solventless antimicrobial compositions |
| US9750927B2 (en) | 2013-03-11 | 2017-09-05 | Becton, Dickinson And Company | Blood control catheter with antimicrobial needle lube |
| US9327095B2 (en) | 2013-03-11 | 2016-05-03 | Becton, Dickinson And Company | Blood control catheter with antimicrobial needle lube |
| US20140276354A1 (en) | 2013-03-14 | 2014-09-18 | Klox Technologies Inc. | Biophotonic materials and uses thereof |
| GB201308770D0 (en) | 2013-05-15 | 2013-06-26 | Convatec Technologies Inc | Wound Dressing Comprising an Antimicrobial Composition |
| WO2015000058A1 (en) * | 2013-07-03 | 2015-01-08 | Klox Technologies Inc. | Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds |
| JP2017509433A (ja) | 2014-04-01 | 2017-04-06 | クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. | 組織充填剤組成物および使用方法 |
| US9789279B2 (en) | 2014-04-23 | 2017-10-17 | Becton, Dickinson And Company | Antimicrobial obturator for use with vascular access devices |
| US10376686B2 (en) | 2014-04-23 | 2019-08-13 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
| US9675793B2 (en) | 2014-04-23 | 2017-06-13 | Becton, Dickinson And Company | Catheter tubing with extraluminal antimicrobial coating |
| US10232088B2 (en) | 2014-07-08 | 2019-03-19 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
| EP3212826B1 (en) | 2014-10-31 | 2020-10-14 | Klox Technologies Inc. | Photoactivatable fibers and fabric media |
| RU2606834C2 (ru) * | 2015-04-17 | 2017-01-10 | Общество с ограниченной ответственностью "РЕВИКСАН" (ООО "РЕВИКСАН") | Гель-фотосенсибилизатор для фотодинамической терапии |
| BR112018001874B1 (pt) | 2015-07-28 | 2022-10-11 | Know Bio, Llc | Métodos de modulação de óxido nítrico em tecido vivo de mamífero |
| US12109429B2 (en) | 2015-07-28 | 2024-10-08 | Know Bio, Llc | Phototherapeutic light for treatment of pathogens |
| US10493244B2 (en) | 2015-10-28 | 2019-12-03 | Becton, Dickinson And Company | Extension tubing strain relief |
| FI130369B (en) * | 2018-10-26 | 2023-07-28 | Koite Health Oy | A method for treating biological surfaces |
| MX2022001416A (es) | 2019-08-02 | 2022-05-26 | Koite Health Oy | Metodo para mejorar la accion antimicrobiana de los antibioticos administrados sistemicamente. |
| US12447354B2 (en) | 2020-03-19 | 2025-10-21 | Know Bio, Llc | Illumination devices for inducing biological effects |
| US11147984B2 (en) | 2020-03-19 | 2021-10-19 | Know Bio, Llc | Illumination devices for inducing biological effects |
| US11986666B2 (en) | 2020-03-19 | 2024-05-21 | Know Bio, Llc | Illumination devices for inducing biological effects |
| US12011611B2 (en) | 2020-03-19 | 2024-06-18 | Know Bio, Llc | Illumination devices for inducing biological effects |
| WO2022040258A1 (en) | 2020-08-21 | 2022-02-24 | University Of Washington | Disinfection method and apparatus |
| US11529153B2 (en) | 2020-08-21 | 2022-12-20 | University Of Washington | Vaccine generation |
| US11425905B2 (en) | 2020-09-02 | 2022-08-30 | University Of Washington | Antimicrobial preventive netting |
| WO2022103775A1 (en) | 2020-11-12 | 2022-05-19 | Singletto Inc. | Microbial disinfection for personal protection equipment |
| US12347337B2 (en) | 2020-12-10 | 2025-07-01 | Know Bio, Llc | Enhanced testing and characterization techniques for phototherapeutic light treatments |
| US11654294B2 (en) | 2021-03-15 | 2023-05-23 | Know Bio, Llc | Intranasal illumination devices |
| US12115384B2 (en) | 2021-03-15 | 2024-10-15 | Know Bio, Llc | Devices and methods for illuminating tissue to induce biological effects |
| US12359369B2 (en) | 2022-08-11 | 2025-07-15 | Singletto Inc. | Skin protection against microbial particles |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4459277A (en) * | 1980-10-07 | 1984-07-10 | Kosti Carl M | Plaque disclosing dentifrice compositions with solid microcapsules of dye |
| SE8206250L (sv) * | 1982-11-03 | 1984-05-04 | Chemical Dynamics Sweden Ab | Reglering av tarmmikroflora |
| US4647578A (en) * | 1983-12-02 | 1987-03-03 | Sterling Drug Inc. | Phototoxic insecticidal compositions and method of use thereof |
| US4634589A (en) * | 1984-05-18 | 1987-01-06 | Wurttembergische Parfumerie-Fabrik Gmbh | Dentifrice for hypersensitive teeth |
| ATE159661T1 (de) * | 1992-04-30 | 1997-11-15 | Eastman Dental Inst | Medikament zur desinfektion der mundhöhle |
| CZ14595A3 (en) * | 1992-07-22 | 1995-10-18 | Unilever Nv | Method of liquidation of surface unbound microorganisms |
| US5798112A (en) * | 1994-12-09 | 1998-08-25 | The United States Of America As Represented By The Secretary Of Agriculture | Phototoxic insecticidal composition and method for controlling insect populations |
| US5713738A (en) * | 1995-12-12 | 1998-02-03 | Britesmile, Inc. | Method for whitening teeth |
| US7390668B2 (en) * | 1996-10-30 | 2008-06-24 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for photodynamic treatment of disease |
| US6084005A (en) * | 1997-02-24 | 2000-07-04 | Kuraray Co., Ltd. | Antimicrobial caries-detecting composition |
| SE511276C2 (sv) * | 1998-01-09 | 1999-09-06 | Mediteam Dentalutveckling I Go | Preparat för användning vid behandling av kariesangrepp |
| IL123437A0 (en) * | 1998-02-24 | 1998-09-24 | Shalev Pinchas | Apparatus and method for photothermal destruction of oral bacteria |
| US6609014B1 (en) * | 1999-04-14 | 2003-08-19 | Qlt Inc. | Use of PDT to inhibit intimal hyperplasia |
| US20020022032A1 (en) * | 1999-04-23 | 2002-02-21 | Curry Patrick Mark | Immuno-adjuvant PDT treatment of metastatic tumors |
| ES2371948T3 (es) * | 1999-08-13 | 2012-01-11 | Provectus Pharmatech, Inc. | Medicamentos tópicos mejorados y métodos para el tratamiento fotodinámico de una enfermedad. |
| JP2001114659A (ja) * | 1999-10-13 | 2001-04-24 | Lion Corp | 口腔用組成物 |
| US6506791B2 (en) * | 2000-08-09 | 2003-01-14 | Jacksonville State University | Method of treatment of protozoan infections in fish |
| US6800086B2 (en) * | 2001-02-06 | 2004-10-05 | Qlt Inc. | Reduced fluence rate PDT |
| BR0212712A (pt) * | 2001-09-03 | 2004-08-03 | Unilever Nv | Kit de higiene oral |
| US20030044114A1 (en) * | 2001-09-06 | 2003-03-06 | Pelka David G. | Source wavelength shifting apparatus and method for delivery of one or more selected emission wavelengths |
| US6561808B2 (en) * | 2001-09-27 | 2003-05-13 | Ceramoptec Industries, Inc. | Method and tools for oral hygiene |
-
2004
- 2004-06-03 US US10/860,297 patent/US20050059731A1/en not_active Abandoned
- 2004-09-03 BR BRPI0414331-0A patent/BRPI0414331B1/pt not_active IP Right Cessation
- 2004-09-03 WO PCT/US2004/028726 patent/WO2005032459A2/en not_active Ceased
- 2004-09-03 EP EP04783086A patent/EP1778294A4/en not_active Withdrawn
- 2004-09-03 JP JP2006526191A patent/JP4943149B2/ja not_active Expired - Fee Related
- 2004-09-03 MX MXPA06003033A patent/MXPA06003033A/es not_active Application Discontinuation
- 2004-09-03 RU RU2006112562/14A patent/RU2368375C2/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1778294A2 (en) | 2007-05-02 |
| MXPA06003033A (es) | 2006-12-14 |
| RU2006112562A (ru) | 2006-08-10 |
| JP4943149B2 (ja) | 2012-05-30 |
| BRPI0414331B1 (pt) | 2018-05-29 |
| WO2005032459A3 (en) | 2006-10-12 |
| JP2007509034A (ja) | 2007-04-12 |
| EP1778294A4 (en) | 2010-05-05 |
| US20050059731A1 (en) | 2005-03-17 |
| WO2005032459A2 (en) | 2005-04-14 |
| RU2368375C2 (ru) | 2009-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2683442B1 (en) | Apparatus for selectively affecting and/or killing bacteria | |
| BRPI0414069A8 (pt) | Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana | |
| WO2005032459A3 (en) | Erythrosin-based antimicrobial photodynamic therapy compound and its use | |
| US6960201B2 (en) | Method for the prevention and treatment of skin and nail infections | |
| Parker | The use of diffuse laser photonic energy and indocyanine green photosensitiser as an adjunct to periodontal therapy | |
| Caccianiga et al. | Clinical, radiographic and microbiological evaluation of high level laser therapy, a new photodynamic therapy protocol, in peri‐implantitis treatment; a pilot experience | |
| BR9507506A (pt) | Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico | |
| BR9712599A (pt) | Processos para o tratamento de um volume particular, de câncer e de um volume de tecido canceroso em tecido e para produzir pelo menos um agente molecular foto-ativo num volume particular de material e aparelhos para o tratamento de um volume particular de tecido de planta ou de animal e para a administração de um tratamento médico foto-dinâmico | |
| DE60308256D1 (de) | Beschichtetes medizinsches Implantat zur Behandlung von Gefässerkrankungen | |
| BR0317747A (pt) | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave | |
| BRPI0618374A2 (pt) | uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo | |
| BRPI0606902A2 (pt) | composto; método para o tratamento de uma doença ou distúrbio associado a atividade excessiva de bace em um paciente que dele necessite; método para modular a atividade de bace; composição farmacêutica | |
| AU5029599A (en) | Methods for eradication of nanobacteria | |
| CY1106259T1 (el) | Συνδυασμενη θepαπεια που πepιλαμβανει zd6474 κι ενα ταξανιο | |
| BR0306196A (pt) | Método de tratamento de infecções endocavitais ou condições anormais de tecido da superfìcie e aparelho para tratamento de local infectado | |
| CY1115407T1 (el) | Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων | |
| DE69607615D1 (de) | Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen | |
| Nammour et al. | Evaluation of dental pulp temperature rise during photo-activated decontamination (PAD) of caries: an in vitro study | |
| BR0313413A (pt) | Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer | |
| DE60018409D1 (de) | Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren | |
| BRPI0712561B8 (pt) | Uso de 3-oxo-3,4-diidro-2-pirazinacarboxamida | |
| BR0312929A (pt) | Uso de um composto, e, métodos de tratamento, prevenção ou alìvio de uma doença, distúrbio ou condição de um corpo de animal vivo, e da degeneração macular relacionada com a idade de um corpo de animal vivo | |
| EP2542305A4 (en) | ADVANCED ANTIMICROBIAL PDT | |
| Bostanciklioglu et al. | Assessment of the effect of laser irradiations at different wavelengths (660, 810, 980, and 1064 nm) on autophagy in a rat model of mucositis | |
| BR0209846B1 (pt) | utilizaÇço de um agente obtido pela irradiaÇço uv artificial de uma soluÇço aquosa para tratamento de esterilizaÇço de instrumentos mÉdicos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: BIOLITEC PHARMA MARKETING LTD. (MY) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG (AT) |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/05/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 15A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2530 DE 02-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |